LIVE NEWS
  • AI costs how much? GitHub Copilot users react to new usage-based pricing system.
  • European Parliament committee votes to scrap US tariffs
  • Hints and Solutions for June 2
  • It has the highest levels of toxic Pfas in drinking water in Scotland. But how did this remote island become awash with forever chemicals? | Pfas
  • For veterans, a place where peace can take root : NPR
  • This common amino acid helped mice survive deadly inflammation
  • Apple Will Reportedly Add Bill-Splitting Feature to iOS 27
  • Opinion | Putin Has No Good Way Out of His War
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • See More
    • Artificial Intelligence
    • Climate Risks
    • Defense
    • Healthcare Innovation
    • Science
    • Technology
    • World
Prime Reports
  • Home
  • Popular Now
  • Crypto
  • Cybersecurity
  • Economy
  • Geopolitics
  • Global Markets
  • Politics
  • Artificial Intelligence
  • Climate Risks
  • Defense
  • Healthcare Innovation
  • Science
  • Technology
  • World
Home»Healthcare Innovation»How STAT would cover ‘The Fugitive’ if its pharma scandal were real
Healthcare Innovation

How STAT would cover ‘The Fugitive’ if its pharma scandal were real

primereportsBy primereportsMarch 14, 2026No Comments2 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
How STAT would cover ‘The Fugitive’ if its pharma scandal were real
Share
Facebook Twitter LinkedIn Pinterest Email


Everyone has those movies they love to watch over and over again. For STATus Report host Alex Hogan, the 1993 thriller “The Fugitive” has been in rotation since he was 8 years old. Recently, Hogan realized the movie’s plot — centered around a pharmaceutical company scandal — is exactly the kind of story STAT would cover if it were real.

(Spoilers ahead …)

The film stars Harrison Ford as Dr. Richard Kimble, who — when not jumping off spillways and dodging bullets — discovers that the fictional pharmaceutical giant Devlin MacGregor is falsifying clinical trial data in order to get a blockbuster treatment for coronary artery disease approved. The drug, RDU-90 (brand name Provasic) was causing liver damage in patients, but Kimble realizes the samples were tampered with to get the drug past the Food and Drug Administration and ostensibly make billions of dollars. 

If something like this actually happened in 2026, it would be an all-hands-on-deck situation here at STAT. We’d have our biotech and pharma reporters covering the scandal, DC reporters finding out what happened at the FDA, and investigative reporters chasing down leads about Devlin MacGregor. 

In this special Oscars season episode of STATus Report, Hogan has engaged STAT’s intrepid reporters to imagine how they would jump into the Provasic scandal if it landed on our desks today.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleWindows 11 is getting support for 1,000 Hz+ monitors soon as part of Insider builds — Microsoft has reportedly increased the refresh rate limit to 5,000 Hz
Next Article Trump announces Ric Grenell is stepping down as Kennedy Center’s president
primereports
  • Website

Related Posts

Healthcare Innovation

This common amino acid helped mice survive deadly inflammation

June 2, 2026
Healthcare Innovation

Clinical Workflow Automation: Where AI Is Making Real Inroads

June 2, 2026
Healthcare Innovation

Medicaid work requirement rules published by Trump’s CMS

June 2, 2026
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Paxton’s win over Cornyn sets up high-stakes Texas clash with Talarico

May 28, 202616 Views

Global Resources Outlook 2024 | UNEP

December 6, 202510 Views

Texas Democrat Talarico claims voting laws are rigged ahead of Paxton race

May 28, 20269 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest Reviews

Subscribe to Updates

Get the latest tech news from FooBar about tech, design and biz.

PrimeReports.org
Independent global news, analysis & insights.

PrimeReports.org brings you in-depth coverage of geopolitics, markets, technology and risk – with context that helps you understand what really matters.

Editorially independent · Opinions are those of the authors and not investment advice.
Facebook X (Twitter) LinkedIn YouTube
Key Sections
  • World
  • Geopolitics
  • Popular Now
  • Artificial Intelligence
  • Cybersecurity
  • Crypto
All Categories
  • Artificial Intelligence
  • Climate Risks
  • Crypto
  • Cybersecurity
  • Defense
  • Economy
  • Geopolitics
  • Global Markets
  • Healthcare Innovation
  • Politics
  • Popular Now
  • Science
  • Technology
  • World
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • DMCA / Copyright Notice
  • Editorial Policy

Sign up for Prime Reports Briefing – essential stories and analysis in your inbox.

By subscribing you agree to our Privacy Policy. You can opt out anytime.
Latest Stories
  • AI costs how much? GitHub Copilot users react to new usage-based pricing system.
  • European Parliament committee votes to scrap US tariffs
  • Hints and Solutions for June 2
© 2026 PrimeReports.org. All rights reserved.
Privacy Terms Contact

Type above and press Enter to search. Press Esc to cancel.